How common was parkinsonism in schizophrenia studies of cariprazine hydrochloride at doses of 1.5–6 mg?

In schizophrenia studies of cariprazine hydrochloride at doses of 1.5–6 mg, parkinsonism was reported in 17.5% of patients (very common), with most adverse reactions mild to moderate in severity.